Business article - April 21, 2026
New Finnish deep-tech startup launched
VTT-originated startup Proteins.1 aims to bring PCR-like amplification and simplicity to omics.
Clinical Trials - April 21, 2026
Novo Nordisk’s etavopivat met both co-primary endpoints in phase 3 trial
The company has announced the topline results from HIBISCUS, a phase 3 trial of once-daily oral etavopivat in adults and adolescents with sickle cell disease (SCD).
Business Award - April 20, 2026
NeutroMap wins BioFinland pitching competition
University of Helsinki student Arina Värä won the sixth BioFinland Pitching Competition with her idea NeutroMap.
Acquisition - April 17, 2026
Saga Diagnostics acquired by Roche
Saga Diagnostics has entered into an agreement to be acquired by Foundation Medicine, an independent subsidiary of Roche, for a deal value of up to USD 595 million, including commercial and regulatory milestone payments.
Biotech Business - April 16, 2026
EIB backs BioLamina with EUR 20 million
The European Investment Bank (EIB) is lending EUR 20 million to BioLamina to expand its development of laminin technologies.
Agreement - April 15, 2026
Novo Nordisk partners with OpenAI
The partnership will apply advanced AI capabilities to analyse complex datasets, identify promising drug candidates, and reduce the time required to move from research to patient, the company states.
